APA (7th ed.) Citation

Y, T., H, W., R, G., T, O., K, Y., S, F., . . . T, U. (2022). Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice. Scientific reports, 12(1), 6082. https://doi.org/10.1038/s41598-022-10374-x

Chicago Style (17th ed.) Citation

Y, Tanaka, et al. "Author Correction: TAS0314, a Novel Multi-epitope Long Peptide Vaccine, Showed Synergistic Antitumor Immunity with PD-1/PD-L1 Blockade in HLA-A*2402 Mice." Scientific Reports 12, no. 1 (2022): 6082. https://doi.org/10.1038/s41598-022-10374-x.

MLA (9th ed.) Citation

Y, Tanaka, et al. "Author Correction: TAS0314, a Novel Multi-epitope Long Peptide Vaccine, Showed Synergistic Antitumor Immunity with PD-1/PD-L1 Blockade in HLA-A*2402 Mice." Scientific Reports, vol. 12, no. 1, 2022, p. 6082, https://doi.org/10.1038/s41598-022-10374-x.